Declining macrolide resistance inStreptococcus pyogenesin Portugal (2007–13) was accompanied by continuous clonal changes

Macrolide-resistantStreptococcus pyogenes: prevalence and treatment strategies

(2015) Catarina Silva-Costa et al.   Expert Review of Anti-Infective Therapy

What causes decreased erythromycin resistance in Streptococcus pyogenes? Dynamics of four clones in a southern European region from 2005 to 2012

(2014) M. Montes et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Differences between Macrolide-Resistant and -Susceptible Streptococcus pyogenes: Importance of Clonal Properties in Addition to Antibiotic Consumption

(2012) C. Silva-Costa et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

PHYLOViZ: phylogenetic inference and data visualization for sequence based typing methods

(2012) Alexandre P Francisco et al.   BMC BIOINFORMATICS

European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997–2009)

(2011) et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Macrolide-resistant Streptococcus pyogenes in Central Greece: prevalence; mechanism and molecular identification

(2010) Ergina Malli et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008)

(2010) C. Ardanuy et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Global optimal eBURST analysis of multilocus typing data using a graphic matroid approach

(2009) Alexandre P Francisco et al.   BMC BIOINFORMATICS

Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal

(2008) C. Silva-Costa et al.   CLINICAL MICROBIOLOGY AND INFECTION

Increasing telithromycin resistance among Streptococcus pyogenes in Europe

(2008) S. S. Richter et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY